federal, drug, administration, US, department, health, human, services, agency, biologics, vaccines, medical devices, diagnosis, treatment, prevention, Drug Views, drugs, Medical, Information, Health, Drugs, Conditions, Pharmacy, Pills http://www.drugviews.com/articles.php en-us Ateom.com - Website Power Tools study of Ketotransdel® (TDLP-110) at the 13th World Congress on Pain in Montreal, Canada.]]> Thu, 02 Sep 2010 09:12:09 -0400 http://www.drugviews.com/articles.php?t=Transdel-Pharmaceuticals-presents-Ketotransdel-Phase-3-data-at-13th-World-Pain-Congress cancer announces that its second Phase III trial evaluating microplasmin for the non-surgical treatment of vitreomacular adhesion (VMA) has met its primary endpoint.]]> Thu, 02 Sep 2010 06:03:24 -0400 http://www.drugviews.com/articles.php?t=ThromboGenics-second-microplasmin-Phase-III-trial-for-non-surgical-treatment-of-VMA-meets-primary-endpoint study published in the September 2010 issue of SHOCK by Dr. Ed W. Childs and colleagues at Scott & White Healthcare looks at how female versus male rats fared after suffering a trauma and subsequent hemorrhagic shock who were given Estradiol (estrogen). In the study, the Estradiol prevented vascular permeability following hemorrhagic shock.]]> Thu, 02 Sep 2010 05:52:14 -0400 http://www.drugviews.com/articles.php?t=Estradiol-prevents-vascular-permeability-following-hemorrhagic-shock-Study drug conjugate (ADC) that is being developed for the treatment of metastatic renal cancer. An ADC uses the specific binding properties of an antibody to target a toxin in tumor cells, resulting in selective tumor cell killing.]]> Thu, 02 Sep 2010 05:29:00 -0400 http://www.drugviews.com/articles.php?t=Agensys-commences-AGS-16M8F-ADC-Phase-I-clinical-trial-for-renal-cancer care, was effective at decreasing lactate levels in treated patients.]]> Thu, 02 Sep 2010 01:08:18 -0400 http://www.drugviews.com/articles.php?t=Sangart-reports-positive-MP4OX-Phase-IIa-study-data-in-severely-injured-trauma-patients-with-hemorrhagic-shock positive results from its Phase IIa proof-of-concept study of MP4OX (oxygenated pegylated hemoglobin) in severely injured trauma patients with hemorrhagic shock causing lactic acidosis. The study demonstrated that MP4OX, when given in addition to standard of care, was effective at decreasing lactate levels in treated patients.]]> Tue, 31 Aug 2010 09:27:19 -0400 http://www.drugviews.com/articles.php?t=Sangart-reports-positive-data-from-MP4OX-Phase-IIa-study-in-trauma-patients blood thinner called unfractionated heparin (UFH) during angioplasty did not reduce bleeding or vascular complications compared to standard dose UFH in patients initially treated with a blood thinner, fondaparinux.]]> Tue, 31 Aug 2010 07:53:00 -0400 http://www.drugviews.com/articles.php?t=Standard-dose-of-UFH-optimal-for-treatment-of-PCI-patients-on-fondaparinux-Study high-risk atrial fibrillation patients unsuitable for treatment with a vitamin K antagonist (warfarin), was terminated early following a recommendation from the Data Monitoring Committee.]]> Tue, 31 Aug 2010 07:05:00 -0400 http://www.drugviews.com/articles.php?t=Phase-3-AVERROES-trial-reveals-apixaban-effective-for-atrial-fibrillation-patients-unsuitable-for-warfarin time. Conventional anti-arrhythmic therapy aims at halting progression and reducing symptoms, but the use of most anti-arrhythmic drugs is compromised by severe side effects, such as pro-arrhythmia or extra-cardiac organ toxicity.]]> Tue, 31 Aug 2010 06:18:00 -0400 http://www.drugviews.com/articles.php?t=ANTIPAF-trial-reveals-ARBs-do-not-reduce-number-of-AF-episodes-in-paroxysmal-AF-patients provide initial evidence that a low dose of unfractionated heparin does not reduce the incidence of bleeding or vascular complications in PCI patients treated with the anticoagulant fondaparinux. Findings showed that the rates of peri-PCI major bleeding were 1.4% in those given low dose heparin and 1.2% the standard dose.]]> Tue, 31 Aug 2010 06:09:19 -0400 http://www.drugviews.com/articles.php?t=Unfractionated-heparin-standard-dose-may-be-optimal-treatment-strategy-in-PCI-patients-on-fondaparinux oral anticoagulant rivaroxaban successfully demonstrated non-inferiority compared to the standard of care for the prevention of recurrent venous thromboembolism (VTE) in patients with acute symptomatic deep vein thrombosis (DVT), with a comparable safety profile.]]> Tue, 31 Aug 2010 05:32:00 -0400 http://www.drugviews.com/articles.php?t=Phase-3-EINSTEIN-DVT-clinical-trial-data-can-transform-deep-vein-thrombosis-treatment anti-thrombotic agent in interventional cardiology for decades, there is still no solid evidence from large clinical trials to guide its dosing during PCI.]]> Tue, 31 Aug 2010 03:05:11 -0400 http://www.drugviews.com/articles.php?t=Reduced-heparin-dose-lowers-bleeding-risk-after-PCI-without-increasing-risk-of-ischaemic-complications drug designed to treat cancers with a particular genetic fault has shown promising results in a small clinical trial.]]> Fri, 27 Aug 2010 04:30:45 -0400 http://www.drugviews.com/articles.php?t=Experimental-drug-PLX4032-holds-promise-against-cancers-with-faulty-BRAF-gene Thu, 26 Aug 2010 23:59:48 -0400 http://www.drugviews.com/articles.php?t=Vanda-Pharmaceuticals-initiates-tasimelteon-Phase-III-clinical-trial-for-Non-24-Hour-Sleep-Wake-Disorder treat patients with inoperable colorectal cancer liver metastases who have failed all standard-of-care chemotherapy options can more than double the time until their disease progresses, according to the final results of a Phase III randomised controlled trial published in the prestigious Journal of Clinical Oncology.]]> Fri, 20 Aug 2010 04:34:00 -0400 http://www.drugviews.com/articles.php?t=Trial-shows-positive-results-for-radioembolisation-technique-for-colorectal-cancer-liver-metastases-treatment product for non-muscle-invasive bladder cancer - Urocidin.]]> Fri, 20 Aug 2010 01:05:09 -0400 http://www.drugviews.com/articles.php?t=Bioniche-provides-update-on-Urocidin-clinical-development-program-for-non-muscle-invasive-bladder-cancer study of Droxidopa, an oral synthetic precursor of norepinephrine, has been initiated in chronic fatigue syndrome (CFS).]]> Fri, 20 Aug 2010 00:54:58 -0400 http://www.drugviews.com/articles.php?t=Chelsea-Therapeutics-announces-new-investigator-to-conduct-phase-II-clinical-study-of-Droxidopa control pill in women with marked weight differences has found that the pill works equally well in women with obesity and thinner women. This new finding by physician-scientists at NewYork-Presbyterian Hospital/Columbia University Medical Center refutes a long-held conviction among many doctors that the pill may not reliably prevent pregnancy in women who are overweight ]]> Tue, 17 Aug 2010 02:00:32 -0400 http://www.drugviews.com/articles.php?t=Oral-contraceptives-equally-effective-for-obese-women depression in women experiencing or about to experience menopause, according to a study released today led by a Virginia Commonwealth University researcher.]]> Tue, 17 Aug 2010 01:19:49 -0400 http://www.drugviews.com/articles.php?t=Antidepressant-alleviates-depression-in-peri-and-postmenopausal-women-Study Mon, 16 Aug 2010 11:56:00 -0400 http://www.drugviews.com/articles.php?t=Emisphere-second-quarter-net-loss-increases-to-13-7-million